Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.49 |
| ▸ | LGALS3 | P17931 | 7/20 | 0.48 |
| ▸ | LGALS8 | O00214 | 4/20 | 0.48 |
| ▸ | LGALS9 | O00182 | 4/20 | 0.48 |
| ▸ | LGALS1 | P09382 | 4/20 | 0.48 |
| ▸ | LGALS7; LGALS7B | P47929 | 4/20 | 0.48 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24145071 | 0.92 | TTR (0.49) | TTRLGALS3LGALS8LGALS9LGALS1 | |
| SCHEMBL23488620 | 0.89 | LGALS3 (0.49) | LGALS3LGALS8LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL23488494 | 0.87 | NPC1 (0.50) | LGALS3LGALS8LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL23488437 | 0.85 | LGALS3 (0.44) | LGALS3LGALS8LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL24137795 | 0.85 | LGALS8 (0.45) | LGALS3LGALS8LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL23488285 | 0.83 | LGALS3 (0.45) | LGALS3LGALS8LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL11371729 | 0.82 | LGALS3 (0.60) | LGALS3LGALS8LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL11368063 | 0.82 | LGALS3 (0.60) | LGALS3LGALS8LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL21112942 | 0.80 | TDP1 (0.56) | TTRACHE | |
| SCHEMBL23488490 | 0.79 | LGALS3 (0.53) | LGALS3LGALS8LGALS9LGALS1LGALS7; LGALS7B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210401946-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-12-30 | — | — | US | disclosed |
| US-20210401947-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-12-30 | — | — | US | disclosed |
| US-20210401947-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-12-30 | — | — | US | disclosed |
| US-11090364-B2 | Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein | SANOFI (FR) | 2021-08-17 | — | — | US | disclosed |
| US-20190209656-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11090364-B2 | Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein | GPR119, SLC2A8, SLC2A4 | TTR 1676/4885LGALS3 210/4885LGALS8 98/4885 |
| US-20190209656-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | TTR 1676/4885LGALS3 210/4885LGALS8 98/4885 |
| US-20210401946-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | TTR 1676/4885LGALS3 210/4885LGALS8 98/4885 |
| US-20210401947-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | TTR 1676/4885LGALS3 210/4885LGALS8 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.